Dashboard
Manage Tickers

ENTX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

entera-bio-announces-publication-of-oral-pth1-34-peptide-tablets-eb613-phase-2-trial-data-i1n-the-journal-of-bone-and-mineral-research
Entera Bio Announces Publication Of Oral P...
04/08/2024 12:33:29

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

hc-wainwright--co-maintains-buy-on-entera-bio-maintains-10-price-target
HC Wainwright & Co. Maintains Buy on Enter...
04/02/2024 12:54:27

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price tar...

entera-bio-announces-key-regulatory-milestone-for-oral-pth1-34-peptide-eb613-phase-3-program-fda-ruling-on-qualifying-bmd-as-a-surrogate-endpoint-for-osteoporosis-drugs-is-expected-within-10-months
Entera Bio Announces Key Regulatory Milest...
03/26/2024 12:33:46

Entera Bio Ltd. (NASDAQ:ENTX) ("Entera" or the "Company"), a leader in the development of orally delivered pept...

entera-bio-announces-pharmacokinetic-data-for-oral-glp-2-peptide-tablet-treatment-for-patients-with-short-bowel-syndrome-says-the-studys-objectives-were-met-with-oral-glp-2-tablets-exhibiting-significant-systemic-exposure
Entera Bio Announces Pharmacokinetic Data ...
03/20/2024 12:03:25

entera-bio-fy23-eps-031-vs-041-yoy-as-of-december-31-2023-entera-had-cash-and-cash-equivalents-of-110m
Entera Bio FY23 EPS $(0.31) Vs $(0.41) YoY...
03/08/2024 21:17:40

Financial Results for the year Ended December 31, 2023As of December 31, 2023, Entera had cash and cash equivalents of $11.0 mi...

entera-bio-regains-compliance-with-nasdaq-minimum-bid-price-requirement
Entera Bio Regains Compliance With Nasdaq ...
03/04/2024 13:47:35

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

entera-bio-and-3-other-stocks-under-1-insiders-are-buying
Entera Bio And 3 Other Stocks Under $1 Ins...
01/12/2024 12:48:34

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or...

entera-bio-announced-that-it-received-an-extension-of-180-calendar-days-from-the-nasdaq-stock-market-to-regain-compliance
Entera Bio Announced That It Received An E...
01/03/2024 13:49:28

hc-wainwright--co-reiterates-buy-on-entera-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Ente...
12/11/2023 11:42:24

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

interim-results-from-ongoing-clinical-study-confirm-eb613-optimized-profile-for-osteoporosis-treatment-and-potential-for-enteras-next-generation-oral-peptide-platform
Interim Results From Ongoing Clinical Stud...
11/29/2023 13:33:37

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

entera-bio-reports-rapid-pharmacodynamic-response-and-consistent-pharmacokinetic-data-for-its-first-in-class-oral-pth1-34-mini-tablets-at-the-asbmr-2023-annual-meeting
Entera Bio Reports Rapid Pharmacodynamic R...
10/16/2023 12:20:22

Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered pept...

hc-wainwright--co-reiterates-buy-on-entera-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Ente...
09/13/2023 10:33:06

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

Core News & Articles
Entera Bio Announces Collaboration with OP...
09/12/2023 12:32:58

Entera Bio Ltd. (NASDAQ:ENTX, ", Entera", )))) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ:OPK,...

hc-wainwright--co-reiterates-buy-on-entera-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Ente...
09/11/2023 10:32:04

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

bioventus-and-3-other-stocks-under-5-insiders-are-buying
Bioventus And 3 Other Stocks Under $5 Insi...
08/23/2023 13:23:06

The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or co...

entera-bio-to-present-two-abstracts-on-its-once-daily-oral-hpth1-34-peptide-tablets-eb613-for-the-treatment-of-post-menopausal-women-at-high-risk-of-fracture-at-the-american-society-for-bone-and-mineral-research-annual-meeting
Entera Bio To Present Two Abstracts On Its...
08/16/2023 12:35:17

hc-wainwright--co-reiterates-buy-on-entera-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Ente...
05/08/2023 10:28:23

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

entera-bio-q1-earnings-insights
Entera Bio: Q1 Earnings Insights
05/05/2023 20:10:10

entera-bio-q1-eps-008-beats-012-estimate
Entera Bio Q1 EPS $(0.08) Beats $(0.12) Es...
05/05/2023 20:07:54

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by...

hc-wainwright--co-reiterates-buy-on-entera-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Ente...
04/04/2023 10:42:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entera Bio (NASDAQ:ENTX) with a Buy and maintains $10 price ta...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)